These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 14583444)
1. Molecular interaction of connexin 30.3 and connexin 31 suggests a dominant-negative mechanism associated with erythrokeratodermia variabilis. Plantard L; Huber M; Macari F; Meda P; Hohl D Hum Mol Genet; 2003 Dec; 12(24):3287-94. PubMed ID: 14583444 [TBL] [Abstract][Full Text] [Related]
2. A new, recurrent mutation of GJB3 (Cx31) in erythrokeratodermia variabilis. Morley SM; White MI; Rogers M; Wasserman D; Ratajczak P; McLean WH; Richard G Br J Dermatol; 2005 Jun; 152(6):1143-8. PubMed ID: 15948974 [TBL] [Abstract][Full Text] [Related]
3. Erythrokeratodermia variabilis: report of two cases and a novel missense variant in GJB4 encoding connexin 30.3. Kokotas H; Papagiannaki K; Grigoriadou M; Petersen MB; Katsarou A Eur J Dermatol; 2012; 22(2):182-6. PubMed ID: 22266302 [TBL] [Abstract][Full Text] [Related]
4. The connexin31 F137L mutant mouse as a model for the human skin disease erythrokeratodermia variabilis (EKV). Schnichels M; Wörsdörfer P; Dobrowolski R; Markopoulos C; Kretz M; Schwarz G; Winterhager E; Willecke K Hum Mol Genet; 2007 May; 16(10):1216-24. PubMed ID: 17446259 [TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations. Richard G; Brown N; Rouan F; Van der Schroeff JG; Bijlsma E; Eichenfield LF; Sybert VP; Greer KE; Hogan P; Campanelli C; Compton JG; Bale SJ; DiGiovanna JJ; Uitto J J Invest Dermatol; 2003 Apr; 120(4):601-9. PubMed ID: 12648223 [TBL] [Abstract][Full Text] [Related]
6. Divergent effects of two sequence variants of GJB3 (G12D and R32W) on the function of connexin 31 in vitro. Rouan F; Lo CW; Fertala A; Wahl M; Jost M; Rodeck U; Uitto J; Richard G Exp Dermatol; 2003 Apr; 12(2):191-7. PubMed ID: 12702148 [TBL] [Abstract][Full Text] [Related]
7. Tissue-specific effects of wild-type and mutant connexin 31: a role in neurite outgrowth. Unsworth HC; Aasen T; McElwaine S; Kelsell DP Hum Mol Genet; 2007 Jan; 16(2):165-72. PubMed ID: 17142249 [TBL] [Abstract][Full Text] [Related]
8. Gap junctions in the inner ear: comparison of distribution patterns in different vertebrates and assessement of connexin composition in mammals. Forge A; Becker D; Casalotti S; Edwards J; Marziano N; Nevill G J Comp Neurol; 2003 Dec; 467(2):207-31. PubMed ID: 14595769 [TBL] [Abstract][Full Text] [Related]
9. A rare missense mutation in GJB3 (Cx31G45E) is associated with a unique cellular phenotype resulting in necrotic cell death. Easton JA; Albuloushi AK; Kamps MAF; Brouns GHMR; Broers JLV; Coull BJ; Oji V; van Geel M; van Steensel MAM; Martin PE Exp Dermatol; 2019 Oct; 28(10):1106-1113. PubMed ID: 29570224 [TBL] [Abstract][Full Text] [Related]
10. Erythrokeratoderma variabilis caused by a recessive mutation in GJB3. Fuchs-Telem D; Pessach Y; Mevorah B; Shirazi I; Sarig O; Sprecher E Clin Exp Dermatol; 2011 Jun; 36(4):406-11. PubMed ID: 21564177 [TBL] [Abstract][Full Text] [Related]
12. Intracellular distribution, assembly and effect of disease-associated connexin 31 mutants in HeLa cells. He LQ; Liu Y; Cai F; Tan ZP; Pan Q; Liang DS; Long ZG; Wu LQ; Huang LQ; Dai HP; Xia K; Xia JH; Zhang ZH Acta Biochim Biophys Sin (Shanghai); 2005 Aug; 37(8):547-54. PubMed ID: 16077902 [TBL] [Abstract][Full Text] [Related]
13. A mutation in GJB3 is associated with recessive erythrokeratodermia variabilis (EKV) and leads to defective trafficking of the connexin 31 protein. Gottfried I; Landau M; Glaser F; Di WL; Ophir J; Mevorah B; Ben-Tal N; Kelsell DP; Avraham KB Hum Mol Genet; 2002 May; 11(11):1311-6. PubMed ID: 12019212 [TBL] [Abstract][Full Text] [Related]
14. [Erythrokeratodermia variabilis (EKV)--a disorder due to altered epidermal expression of gap junction proteins]. Ständer S; Stadelmann A; Traub O; Traupe H; Metze D J Dtsch Dermatol Ges; 2005 May; 3(5):354-8. PubMed ID: 16372802 [TBL] [Abstract][Full Text] [Related]
15. Gap junction diseases of the skin. van Steensel MA Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):12-9. PubMed ID: 15468169 [TBL] [Abstract][Full Text] [Related]
16. Novel and recurrent connexin 30.3 and connexin 31 mutations associated with erythrokeratoderma variabilis. Scott CA; O'Toole EA; Mohungoo MJ; Messenger A; Kelsell DP Clin Exp Dermatol; 2011 Jan; 36(1):88-90. PubMed ID: 21188847 [TBL] [Abstract][Full Text] [Related]
17. Pathogenic Cx31 is un/misfolded to cause skin abnormality via a Fos/JunB-mediated mechanism. Tang C; Chen X; Chi J; Yang D; Liu S; Liu M; Pan Q; Fan J; Wang D; Zhang Z Hum Mol Genet; 2015 Nov; 24(21):6054-65. PubMed ID: 26251042 [TBL] [Abstract][Full Text] [Related]
18. Defective trafficking and cell death is characteristic of skin disease-associated connexin 31 mutations. Di WL; Monypenny J; Common JE; Kennedy CT; Holland KA; Leigh IM; Rugg EL; Zicha D; Kelsell DP Hum Mol Genet; 2002 Aug; 11(17):2005-14. PubMed ID: 12165562 [TBL] [Abstract][Full Text] [Related]
19. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Richard G; Smith LE; Bailey RA; Itin P; Hohl D; Epstein EH; DiGiovanna JJ; Compton JG; Bale SJ Nat Genet; 1998 Dec; 20(4):366-9. PubMed ID: 9843209 [TBL] [Abstract][Full Text] [Related]
20. Specific amino-acid residues in the N-terminus and TM3 implicated in channel function and oligomerization compatibility of connexin43. Lagree V; Brunschwig K; Lopez P; Gilula NB; Richard G; Falk MM J Cell Sci; 2003 Aug; 116(Pt 15):3189-201. PubMed ID: 12829738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]